Therapeutic Applications of Fatty Acid Amide Hydrolase Inhibitors

Fatty acid amide hydrolase (FAAH) is an enzyme responsible for the degradation of oleamide (an endogenous sleep-inducing lipid) and anandamide (an endogenous ligand for cannabinoid receptors). Disclosed herein are potent inhibitors of FAAH and methods for their use for treating a variety of disorder, including hypertension and cardiac hypertrophy.

Patents:
WO 2,009,051,666

Inventor(s): KUNOS GEORGE [US]; MAKRIYANNIS ALEXANDROS [US]

Type of Offer: Licensing



« More Medical Patents

---